Kymera Therapeutics, Inc.
KYMR Healthcare Biotechnology
Kymera Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 16.7% from fiscal 2024.
- Revenue
- +466.4%
- EPS
- −40.3%
- Free cash flow
- −186.6%
- Total debt
- −66.6%
Quarter to September 2026, against a year earlier
Follow KYMR
Alert me
Kymera Therapeutics, Inc. (KYMR) Operating margin
Kymera Therapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was 0.00%, up 891.1 percentage points from fiscal 2025 (−891.1%). Over the past ten years it has ranged from −1,438.5% (fiscal 2019) to 0.00% (fiscal 2018); the current reading is higher than 25% of that period. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −891.1% | (335.25) |
| FY2024 | −555.8% | (345.20) |
| FY2023 | −210.6% | 133.75 |
| FY2022 | −344.4% | (206.34) |
| FY2021 | −138.0% | (1.98) |
| FY2020 | −136.1% | 1,302.43 |
| FY2019 | −1,438.5% | (1,438.48) |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 0.00% | 116.32 |
| Jun 2026 | −116.3% | 128.56 |
| Mar 2026 | −244.9% | 3,164.91 |
| Dec 2025 | −3,409.8% | (62.43) |
| 24 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| TECH Bio-Techne Corp compare | 20.7% |
| TGTX TG Therapeutics, Inc. compare | 17.1% |
| CAI Caris Life Sciences,�Inc. compare | 13.4% |
| BMRN BioMarin Pharmaceutical Inc. compare | 3.12% |
| PCVX Vaxcyte, Inc. compare | 0.00% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| KYMR Kymera Therapeutics, Inc. | 0.00% |
| TWST Twist Bioscience Corporation compare | −33.6% |
| IBRX ImmunityBio, Inc. compare | −151.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on KYMR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement